Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Avivomed has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
Avivomed is headquartered in Minneapolis, United States.
Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.
Avivomed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avivomed — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/avivomed. Accessed November 18, 2026.
VCBacked. (2021). Avivomed — Funding & Investors. Retrieved November 18, 2026, from https://www.vcbacked.co/company/avivomed
{{cite web |title=Avivomed — Funding & Investors |url=https://www.vcbacked.co/company/avivomed |website=VCBacked |access-date=November 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Avivomed? Request a listing update